ZoomMed Acquires Praxis Sante
11 Février 2011 - 2:00PM
Marketwired
ZoomMed Inc. (TSX VENTURE: ZMD). ZoomMed is proud to announce the
acquisition of Praxis Sante Inc. This acquisition contributes to
consolidate and add value to ZoomMed's e-Pic communication network
between physicians and pharmacists. Furthermore, it broadens the
scope of its network, a powerful intercommunication tool between
pharmaceutical companies, physicians and now the pharmacists.
Accordingly, a portion of the aggregate counterpart payable for
the acquisition by the Corporation will be made through the
issuance of a maximum of 3,500,000 common shares of ZoomMed at a
deemed price of $0.20 per common share and the payment of $800,000
in cash to Praxis Sante Inc's shareholders.
Praxis Sante Inc. has developed complete management software's
for patients' files of pharmacists, based on Web technologies
perfectly compatible with the technology used by ZoomMed Inc. As it
is at a development stage, according to the non audited financial
statements as of December 31, 2010, Praxis Sante Inc. has incomes
of $123,793, net benefit of $43,912, cumulated loss of $3,641,
assets of $404,318 and liabilities of $107,859. Nevertheless, the
counterpart reflects the great potential of the technologies of
Praxis Sante Inc. Indeed, this acquisition enables ZoomMed to
diversify and consolidate its position in the Canadian Healthcare
network, concurrently to its recent announcement regarding the
launching and penetration of the important American Market.
At a time where the different Healthcare networks in
North-America are looking for state of the art solutions to
optimize collaboration and information exchanges between Health
Professionals, ZoomMed can now capitalize on a powerful application
portfolio that will allow it to bring a significant contribution
towards the fulfillment of those objectives. One of the principal
causes of problems that physicians and pharmacists have in adhering
to major governmental Electronic Medical Record type projects
pertain to their own outdated applications and technology.
ZoomMed's solutions are state of the art Web based applications.
They are not only very user friendly to health care professionals,
but can easily be interfaced with different private initiatives and
Government projects, without the risk of disturbing their own IT
operations.
This transaction is subject to the approval of the TSX Venture
Exchange and other regulatory authorities.
About ZoomMed
ZoomMed's developed the ZRx Prescriber, a technological
innovative Web application that enables physicians to use a
wireless device, such as the IPod Touch™, IPhone™, IPad™, Google
Android™, other PDA's or computers, to write and rapidly deliver
scripts. The ZRx Prescriber is quick, efficient and intuitive.
Since it is a stand-alone product, it can easily be integrated to
any Electronic Medical Record application (EMR).
About Praxis Sante
PraxisLab is a new application that enhances all aspects of the
prescription filling process and the complete pharmacists patient
file management. Fast, efficient and user friendly, its unique
development concept provides a fast access to all its
functionalities, thus allowing its users to be productive with a
minimum training. PraxisLab uses state-of-the-art protocols and
up-to-date software standards, allowing high compatibility with
existing software, as well as new generation software.
For further information about Praxis Sante Inc., please visit
the Web Site; www.praxissante.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: ZoomMed Mr. Yves Marmet President and Chief Executive
Officer 450-678-5457, Ext 228 info@zoommed.com www.zoommed.com
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024